相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toxicological Study and Efficacy of Blank and Paclitaxel-Loaded Lipid Nanocapsules After i.v. Administration in Mice
Jose Hureaux et al.
PHARMACEUTICAL RESEARCH (2010)
Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields
Michael Chorny et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Juliana M. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth
Khuloud T. Al-Jamal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases
Biana Godin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery
Juliana M. Chan et al.
BIOMATERIALS (2009)
Activation of NAD(P) H:Quinone Oxidoreductase 1 Prevents Arterial Restenosis by Suppressing Vascular Smooth Muscle Cell Proliferation
Sun-Yee Kim et al.
CIRCULATION RESEARCH (2009)
Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden.
Stefan K. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
Liangfang Zhang et al.
ACS NANO (2008)
The future of drug-eluting stents
Neville Kukreja et al.
PHARMACOLOGICAL RESEARCH (2008)
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Frank Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
E. Pereverzeva et al.
TOXICOLOGY LETTERS (2008)
Nanoparticles in medicine: Therapeutic applications and developments
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Late coronary stent thrombosis
Stephan Windecker et al.
CIRCULATION (2007)
Vascular responses to drug eluting stents - Importance of delayed healing
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis
Einat Cohen-Sela et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Drug therapy - Coronary-artery stents
PW Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pathophysiology of coronary artery disease
P Libby et al.
CIRCULATION (2005)
Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits
HD Danenberg et al.
CIRCULATION (2003)
Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats
T Uwatoku et al.
CIRCULATION RESEARCH (2003)
Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel
FD Kolodgie et al.
CIRCULATION (2002)
Biochemical analysis of collagen and elastin synthesis in the balloon injured rat carotid artery
NF Nili et al.
CARDIOVASCULAR PATHOLOGY (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model
I Fishbein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
SC Kim et al.
JOURNAL OF CONTROLLED RELEASE (2001)
分享论文
